Webinar | December 27, 2018

Immuno-Gene Therapeutics In Hematological Cancers: How Science Drives Study Strategy

Source: Premier Research

This webinar reviews the current state of technology in gene therapeutics and examines trends in immuno-oncology and gene therapy for hematological malignancies. Topics include:

  • Ingredients for successful study planning and delivery
  • Operationalizing studies to achieve conclusive data outcomes
  • Data-driven approach to choosing the right sites in the right countries
  • Key drivers to retaining patients and meeting study endpoints
  • Exploring future trajectories in outsourcing models for innovative biotech companies

Speakers: Luke Gill, Executive Director, Oncology, Strategic Development, Premier Research and Colin Hayward, Chief Medical Officer, Premier Research